Combination of TATE and PD-1 Inhibitor in Liver Cancer
- Status
- RECRUITING
- Phase
- PHASE2
Clinical Trials Related to Hepatocellular Carcinoma
Related studies linked through entity extraction aliases.
Safety of Transarterial Chemoembolization (TACE) in the Setting of an Elevated Bilirubin
- Status
- COMPLETED
- Phase
- PHASE1
Genome Studies of Hepatocellular Carcinoma Developed in Hepatitis C Patients With Sustained Virological Response
- Status
- COMPLETED
- Phase
- N/A
Impact of Y90 Radiation Segmentectomy on HCC
- Status
- COMPLETED
- Phase
- NA
Study of Chiauranib in Patients With Advanced Hepatocellular Carcinoma
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Targeted and Staged Cyber Knife Combined With Interventional Therapy in the Treatment of MHCC
- Status
- UNKNOWN
- Phase
- NA
Cytidine-phosphate-guanosine (CpG) DNA in Hepatocellular Carcinoma Combination Therapy
- Status
- UNKNOWN
- Phase
- PHASE1
Hepatocellular Carcinoma Registry in Asia: The INSIGHT Registry
- Status
- COMPLETED
- Phase
- N/A
A Study of Atezolizumab (Tecentriq®) in Ministry of Food and Drug Safety (MFDS)-Approved Indication(s)
- Status
- COMPLETED
- Phase
- N/A
QUILT-3.055: A Study of Combination Immunotherapies in Patients Who Have Previously Received Treatment With Immune Checkpoint Inhibitors
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
MicroRNAs as Diagnostic Biomarkers in Hepatocellular Carcinoma Among Somali Patients
- Status
- UNKNOWN
- Phase
- N/A
Nivolumab With or Without Ipilimumab in Treating Patients With Resectable Liver Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Pravastatin Intervention to Delay Hepatocellular Carcinoma Recurrence
- Status
- TERMINATED
- Phase
- PHASE2
The Effect of Urea Cream on Sorafenib-associated Hand-Foot Skin Reaction
- Status
- COMPLETED
- Phase
- PHASE4
Surefire Institutional DEB-TACE
- Status
- UNKNOWN
- Phase
- NA
Recombinant Human Endostatin(Rh-endostatin) Combine With Radiotherapy in the Treatment of Hepatocellular Carcinoma(HCC)
- Status
- UNKNOWN
- Phase
- PHASE2
Biomarker Analyses in Hepatocellular Carcinoma (HCC) Patients Treated With TheraSphere®
- Status
- TERMINATED
- Phase
- N/A
Stereotactic Body Radiotherapy (SBRT) Followed by Immunotherapy in Liver Cancer
- Status
- TERMINATED
- Phase
- PHASE1
IMA970A Plus CV8102 in Very Early, Early and Intermediate Stage Hepatocellular Carcinoma Patients
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Perflutren Protein-Type A Microspheres and Contrast-Enhanced Ultrasound in Improving Response to Radioembolization Therapy in Patients With Liver Cancer
- Status
- COMPLETED
- Phase
- PHASE2